ZEAL:CPH
Zealand Pharma A/S
225,50 DKK
arrow_downward
-0,79%(-1,80) 1D
15 հոկ, 13:39:33 GMT+2 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZEAL...
Open
227,00 DKK
High
227,90 DKK
Low
225,00 DKK
Mkt. cap
16,56 մլրդ
Avg. vol.
402,85 հզր
Volume
116,67 հզր
52-wk high
556,00 DKK
52-wk low
225,00 DKK
Shares outstanding
71,61 մլն
No. of employees
578
Open
227,00 DKK
High
227,90 DKK
Low
225,00 DKK
Mkt. cap
16,56 մլրդ
Avg. vol.
402,85 հզր
Volume
116,67 հզր
52-wk high
556,00 DKK
52-wk low
225,00 DKK
Shares outstanding
71,61 մլն
No. of employees
578
News stories
From web sources and news partners
Euronext Markets: Real-time Stock Market Data | live
·
1 օր առաջ
Zealand Pharma, Generate strike AI obesity drug deal worth up to $1.2 billion
Profile
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
About Zealand Pharma A/S